Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America

Table 3 Clinical and demographic characteristics of patients with inflammatory bowel disease who developed tuberculosis from a referral center

Sex/age	IBD type	IBD duration (months)	Previous TB	Treatment during TB	Anti TNF-α time before TB (months)	Chest X-ray screening LTBI	TST screening LTBI	LTBI treatment	Diagnostic TB	TB location
F/23	CD	26	No	IFX + AZA	9	Normal	Negative	No	Smear	Pulmonary
F/30	CD	180	No	IFX + AZA	45	Normal	Negative	No	Biopsy	Pleural
M/45	CD	144	No	ADA + AZA	3	Normal	Negative	No	Biopsy	Pleural
M/31	CD	132	No	ADA + AZA	24	Normal	Negative	No	Sputum culture	Pulmonary
M/32	UC	36	No	MSL		Changed	Negative	Yes	Sputum culture	Pulmonary
M/38	UC	96	No	MSL		Normal	Positive	Yes	Sputum culture	Pulmonary
M/63	UC	180	No	MSL + AZA		Normal	NR	No	Smear	Pulmonary
M/61	UC	96	No	AZA		Changed	Positive	Yes	Sputum culture	Pulmonary

IBD: Inflammatory bowel disease; CD: Crohn's disease; UC: Ulcerative colitis; TB: Tuberculosis; NR: No registry; LTBI: Latent tuberculosis infection; TST: Tuberculin skin test; IFX: Infliximab; ADA: Adalimumab; AZA: Azathioprine; MSL: Mesalazine.